Evidence map›Paper›PMID 41856795›Full record

ArticleJournal of neuroendocrinology2026

Alk-Fam150b (augmentor α) expression in the paraventricular nucleus of the mouse hypothalamus at molecular resolution, and its sensitivity to acute stress.

Laurent Gueissaz, Spyridon Sideromenos, Evgenii O Tretiakov, Robert Schnell, Tibor Harkany

Abstract read
In one paragraph

Article in Journal of neuroendocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laurent GueissazDepartment of Neuroscience, Biomedicum 7D, Karolinska Institutet, Solna, Sweden.
Spyridon SideromenosDepartment of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Evgenii O TretiakovDepartment of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Robert SchnellDepartment of Neuroscience, Biomedicum 7D, Karolinska Institutet, Solna, Sweden.
Tibor HarkanyDepartment of Neuroscience, Biomedicum 7D, Karolinska Institutet, Solna, Sweden.ORCID https://orcid.org/0000-0002-6637-5900

Funding

Austrian Science Fund 10.55776/COE16European Research Council 2020-AdG-101021016Hjärnfonden FO2022-0300Novo Nordisk Fonden NNF23OC0084476Vetenskapsrådet 2023-03058
6 · The paper itself

Abstract

Augmentor α (Fam150b)-induced activation of the ALK receptor (Alk) has gained significance as a hypothalamic signaling pathway with relevance to the control of food intake and energy homeostasis. In contrast, much less is known about the sensitivity of Fam150b-Alk expression and signaling upon noxious challenges. In this regard, acute stress is of particular interest because augmentor α, released from afferents of the food intake circuit of the arcuate nucleus within the paraventricular hypothalamus (PVN), could link stress-induced changes in food consumption. Nevertheless, conflicting data exist on whether Fam150b mRNA is expressed in the PVN. Here, we combined single-cell RNA-seq and multiplexed in situ hybridization to demonstrate that both Fam150b and Alk are expressed in the PVN of adult mice, including corticotropin-releasing hormone (CRH)-containing neurons. As such, a dichotomy of CRH neurons is present through their mutually exclusive expression of either Fam150b or Scgn (secretagogin). Fam150b and Alk were not co-expressed. When inducing inflammation-associated stress, Fam150b but not Alk mRNA expression increased in a mifepristone-sensitive manner, implying regulation by peripheral glucocorticoid feedback. We suggest that augmentor α-ALK signaling could underpin, at least partly, stress-induced changes in feeding and the control of body weight.

Indexed as

Paraventricular Hypothalamic NucleusStress, PhysiologicalAnimalsCorticotropin-Releasing HormoneMaleMiceMice, Inbred C57BLNeuronsSignal TransductionCorticotropin-Releasing Hormonecellular heterogeneityintercellular signalingmelanocortinsneuronal classification

Identifiers

PMID41856795
PMCPMC13002349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.